Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children-Reference-Cited by-同舟云学术

Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children

Published:1999-12 Issue:6 Volume:34 Page:1048-1055
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Dall'Amico Roberto,Ghiggeri GianMarco,Carraro Michele,Artero Mary,Ghio Luciana,Zamorani Edgarda,Zennaro Cristina,Basile Giancarlo,Montini Giovanni,Rivabella Lucia,Cardillo Massimo,Scalamogna Mario,Ginevri Fabrizio

Publisher

Elsevier BV

Subject

Nephrology

Reference29 articles.

1. Epidemiology of idiopatic glomerular disease: A prospective study;Tiebosch;Kidney Int,1987

2. Primary focal segmental glomerulosclerosis: Clinical course and response to therapy;Kobert;Am J Kidney Dis,1994

3. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: Successful treatment with oral cyclophosphamide;Kershaw;Clin Transplant,1994

4. Prompt remission of post-renal transplant nephrotic syndrome with high-dose cyclosporine;Srivastava;Pediatr Nephrol,1994

5. Recurrent focal glomerulosclerosis: Natural history and response to therapy;Artero;Am J Med,1992

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

2. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements;Kidney International;2023-12

3. Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantation;Current Opinion in Nephrology & Hypertension;2023-11-03

4. Incidence, risk factors, and outcomes of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: A systematic review and meta‐analysis;Clinical Transplantation;2023-09-19

5. Successful global anti‐B‐cell strategy with daratumumab in a patient with post‐transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab;Pediatric Transplantation;2023-05-25